Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine administered according to an alternative dosing schedule compared with the standard dosing schedule in healthy women aged 15 to 25 years: results from a randomized study / Esposito, Susanna Maria Roberta; V., Birlutiu; P., Jarcuska; A., Perino; S. C., Man; R., Vladareanu; D., Meric; K., Dobbelaere; F., Thomas; D., Descamps. - In: THE PEDIATRIC INFECTIOUS DISEASE JOURNAL. - ISSN 0891-3668. - 30:3(2011), pp. e49-e55. [10.1097/INF.0b013e318206c26e]
Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine administered according to an alternative dosing schedule compared with the standard dosing schedule in healthy women aged 15 to 25 years: results from a randomized study
Esposito, Susanna Maria Roberta;
2011-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
